EX-19.1 3 ex191-goodrxupdatedinsider.htm EX-19.1

Exhibit 19.1

GoodRx Holdings, Inc.

Insider Trading Compliance Policy

I.Summary

Preventing insider trading is necessary to comply with securities laws and to preserve

the reputation and integrity of GoodRx Holdings, Inc. (the “Company”) as well as that of all

persons affiliated with the Company. Insider trading is a crime. The penalties for violating

insider trading laws include imprisonment, disgorgement of profits, civil fines, and significant

criminal fines. Insider trading is prohibited by this Insider Trading Compliance Policy (this

“Policy”), and violation of this Policy may result in Company-imposed sanctions, including

termination of employment for cause.

This Policy applies to all officers, directors and employees of the Company. For

purposes of this Policy, “officers” refer to those individuals who meet the definition of

“officer” under Section 16 of the Securities Exchange Act of 1934 (as amended, the

“Exchange Act”). Individuals subject to this Policy are responsible for ensuring that members

of their households also comply with this Policy. This Policy also applies to any entities

controlled by individuals subject to this Policy, including any corporations, limited liability

companies, partnerships or trusts (such entities, together with all officers, directors and

employees of the Company, are referred to as the “Covered Persons”), and transactions by

these entities should be treated for the purposes of this Policy and applicable securities laws as

if they were for the individual’s own account.

Notwithstanding the foregoing, any entity that is party to the Stockholders Agreement

entered into in connection with the Company’s initial public offering (the “Stockholders

Agreement”), and their affiliated entities, shall not be subject to this Policy; provided that any

such entity must be subject to policies or procedures designed to ensure compliance with

federal securities laws and regulations prohibiting trading in the securities of a company on the

basis of material, non-public information and, provided further, that any director designated to

the Company’s Board of Directors pursuant to the Stockholders Agreement shall be subject to

this Policy. This Policy extends to all activities within and outside an individual’s Company

duties. Every officer, director and employee must review this Policy.

Questions regarding the Policy should be directed to the Company’s General Counsel.

II.Statement of Policies Prohibiting Insider Trading

No officer, director or employee shall purchase or sell any type of security while in

possession of material, non-public information relating to the security or its issuer, whether

the issuer of such security is the Company or any other company. For example, if a director,

officer or employee learns material non-public information about another company with

which the Company does business, including a business partner or collaborator, that person

may not trade in such other company’s securities until the information becomes public or is

no longer material. Further, no Covered Person shall purchase or sell any security of any

other company in the Company’s industry or the industry of a company that is the subject of

a potential strategic transaction with the Company, while in possession of material

nonpublic information that was obtained in the course of the Covered Person’s employment

or service with the Company.

These prohibitions do not apply to the following “permitted transactions”:

●purchases of the Company’s securities by a Covered Person from the

Company, including without limitation pursuant to an employee stock

purchase plan, enrollment to participate in employee stock purchase plan by

a Covered Person, or sales of the Company’s securities by a Covered Person

to the Company;

●exercises of stock options or other equity awards or the surrender of shares to

the Company in payment of the exercise price or in satisfaction of any tax

withholding obligations in a manner permitted by the applicable equity

award agreement, or vesting of equity-based awards, that in each case do not

involve a market sale of the Company’s securities (the “cashless exercise” of

a Company stock option through a broker does involve a market sale of the

Company’s securities, and therefore would not qualify under this exception);

●purchases or sales of the Company’s securities made pursuant to any binding

contract, specific instruction or written plan entered into outside of a black-

out period and while the purchaser or seller, as applicable, was unaware of

any material, non-public information and which contract, instruction or plan

(i) meets all of the requirements of the affirmative defense provided by Rule

10b5-1 (“Rule 10b5-1”) promulgated under the Securities Exchange Act of

1934, as amended (the “1934 Act”), (ii) was pre-cleared in advance pursuant

to this Policy and (iii) has not been amended or modified in any respect after

such initial pre- clearance without such amendment or modification being

pre-cleared in advance pursuant to this Policy. For more information about

Rule 10b5-1 trading plans, see Section VI below; or

●purchases or sales of the Company’s securities made pursuant to a “non-Rule

10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K that

(i) was entered into outside of a black-out period and while the Covered

Person was unaware of any material, non-public information, (ii) has been

pre-cleared by the General Counsel and (iii) has not been modified after such

initial pre-clearance without such amendment or modification being pre-

cleared in advance by the General Counsel.

In addition, no officer, director or employee shall directly or indirectly communicate

(or “tip”) material, non-public information to anyone outside of the Company (except in

accordance with the Company’s policies regarding the protection or authorized external

disclosure of Company information) or to anyone within the Company other than on a need-

to-know basis.

III.Explanation of Insider Trading

“Insider trading” refers to the purchase or sale of a security while in possession of

“material,” “non-public” information relating to the security or its issuer.

“Securities” include stocks, bonds, notes, debentures, options, warrants and other

convertible securities, as well as derivative instruments.

“Purchase” and “sale” are defined broadly under the federal securities law.

“Purchase” includes not only the actual purchase of a security, but any contract to purchase

or otherwise acquire a security. “Sale” includes not only the actual sale of a security, but

any contract to sell or otherwise dispose of a security. These definitions extend to a broad

range of transactions, including conventional cash-for-stock transactions, conversions, gifts,

the exercise of stock options, and acquisitions and exercises of warrants or puts, calls or

other derivative securities.

A.What Facts are Material?

The materiality of a fact depends upon the circumstances. A fact is considered

“material” if there is a substantial likelihood that a reasonable investor would consider it

important in making a decision to buy, sell or hold a security, or if the fact is likely to have a

significant effect on the market price of the security. Material information can be positive or

negative and can relate to virtually any aspect of a company’s business or to any type of

security, debt or equity. Also, information that something is likely to happen in the future—

or even just that it may happen—could be deemed material.

Examples of material information include (but are not limited to) information about:

●corporate earnings or earnings forecasts;

●possible mergers, acquisitions, tender offers or dispositions;

●major new products or product developments;

●important business developments such as developments

regarding strategic collaborations or joint ventures;

●significant incidents involving cybersecurity or data protection;

●management or control changes;

●significant financing developments including pending public sales or offerings

of debt or equity securities; defaults on borrowings;

●bankruptcies;

●cybersecurity or data security incidents; and

●significant litigation or regulatory actions.

A good general rule of thumb: When in doubt, do not trade.

B.What is Non-Public?

Information is “non-public” if it is not available to the general public. In order for

information to be considered “public”, it must be widely disseminated in a manner that

makes it generally available to investors in a Regulation FD-compliant method, such as

through a press release, a filing with the U.S. Securities and Exchange Commission (the

“SEC”) or a Regulation FD-compliant conference call. The circulation of rumors, even if

accurate and reported in the media, does not constitute effective public dissemination. In

addition, even after a public announcement, a reasonable period of time must lapse in order

for the market to react to the information.

The laws and regulations concerning insider trading are complex, and Covered

Persons are encouraged to seek guidance from the General Counsel prior to considering a

transaction in securities.

IV.Statement of Procedures Preventing Insider Trading

The following procedures have been established, and will be maintained and

enforced, by the Company to prevent insider trading. Every officer, director and designated

employee is required to follow these procedures.

A.Pre-Clearance of All Trades by All Officers, Directors and Certain Employees

To provide assistance in preventing inadvertent violations of applicable securities

laws and to avoid the appearance of impropriety in connection with the purchase and sale of

the Company’s securities, all transactions in the Company’s securities (including

without limitation, acquisitions and dispositions of Company stock, gifts, the exercise

of stock options and the sale of Company stock issued upon exercise of stock options)

by officers, directors and such other employees as are designated by the Board of

Directors, the Chief Executive Officer, Chief Financial Officer or the General Counsel

as being subject to this pre-clearance process (each, a “Pre- Clearance Person”) must

be pre-cleared by the Company’s General Counsel. Pre-clearance does not relieve anyone

of his or her responsibility under SEC rules. For the avoidance of doubt, any designation by

the Board of Directors of the employees who are subject to pre-clearance may be updated

from time to time by the Chief Executive Officer, the Chief Financial Officer or the General

Counsel.

A request for pre-clearance in writing (including without limitation by e-mail),

should be made at least two (2) business days in advance of the proposed transaction and

should include the identity of the Pre-Clearance Person, the type of proposed transaction

(for example, an open market purchase, a privately negotiated sale, a gift, an option

exercise, etc.), the proposed date of the transaction and the number of shares, options or

other securities to be involved. In addition, unless otherwise determined by the General

Counsel, the Pre-Clearance Person must execute a certification (in the form approved by the

General Counsel) that he, she or it is not aware of material, non-public information about

the Company. The General Counsel shall have sole discretion to decide whether to clear any

contemplated transaction, provided that the Chief Financial Officer shall have sole

discretion to decide whether to clear transactions by the General Counsel or persons or

entities subject to this policy as a result of their relationship with the General Counsel. All

trades that are pre-cleared must be effected within five business days of receipt of the pre-

clearance unless a specific exception has been granted by the General Counsel (or the Chief

Financial Officer, in the case of the General Counsel or persons or entities subject to this

policy as a result of their relationship with the General Counsel). A pre-cleared trade (or any

portion of a pre-cleared trade) that has not been effected during the five business day period

must be pre-cleared again prior to execution. Notwithstanding receipt of pre- clearance, if

the Pre-Clearance Person becomes aware of material, non-public information or becomes

subject to a black-out period before the transaction is effected, the transaction may not be

completed.

B.Black-Out Periods

No officer, director or other employee designated by the Board of Directors, the

Chief Executive Officer, the Chief Financial Officer or the General Counsel as being

subject to quarterly blackout periods shall purchase, sell or otherwise dispose of any

security of the Company during the period beginning at 11:59 p.m., Eastern time, on

the 14th calendar day before the end of any fiscal quarter of the Company and ending

upon the completion of the second full trading day after the public release of earnings

data for such fiscal quarter or during any other trading suspension period declared by

the Company, except for purchases and sales made pursuant to the permitted transactions

described in Section II. For example, if the Company’s fourth fiscal quarter ends at 11:59

p.m., Eastern time, on December 31, the corresponding blackout period would begin at

11:59 p.m., Eastern time, on December 17. For the avoidance of doubt, any designation by the

Board of Directors of the employees who are subject to quarterly blackout periods may be updated

from time to time by the -Chief Executive Officer, Chief Financial Officer or General Counsel.

Exceptions to the black-out period policy may be approved only by the Company’s

General Counsel (or, in the case of an exception for the General Counsel or persons or

entities subject to this policy as a result of their relationship with the General Counsel, the

Chief Financial Officer or, in the case of exceptions for directors or persons or entities

subject to this policy as a result of their relationship with a director, the Board of Directors).

From time to time, the Company, through the Board of Directors, the Company’s

disclosure committee, the Chief Financial Officer or the General Counsel, may recommend

that officers, directors, employees or others suspend trading in the Company’s securities

because of developments that have not yet been disclosed to the public. Subject to the

exceptions noted above, all of those affected should not trade in the Company’s securities

while the suspension is in effect, and should not disclose to others that the Company has

suspended trading. Any trading suspension will remain effective until revoked by the

General Counsel or his or her designee.

If the Company is required to impose a “pension fund black-out period” under

Regulation BTR, each director and executive officer shall not, directly or indirectly sell,

purchase or otherwise transfer during such black-out period any equity securities of the

Company acquired in connection with his or her service as a director or officer of the

Company, except as permitted by Regulation BTR.

C.Post-Termination Transactions

If an individual is in possession of material, non-public information when his or her

service terminates, that individual may not trade in the Company’s securities until that

information has become public or is no longer material.

V.Additional Prohibited Transactions

Officers, directors and employees shall comply with the following policies with

respect to certain transactions in the Company securities:

A.Short Sales

Short sales of the Company’s securities are prohibited by this Policy. In addition,

Section 16(c) of the 1934 Act absolutely prohibits Section 16 reporting persons (i.e.,

directors, certain officers and the Company’s 10% stockholders) from making short sales of

the Company’s equity securities, i.e., sales of shares that the insider does not own at the

time of sale, or sales of shares against which the insider does not deliver the shares within

20 days after the sale.

B.Options

Options trading, including puts, calls, or other derivative securities on an exchange,

an over-the-counter market, or any other organized market is prohibited by this Policy.

C.Hedging Transactions

Hedging transactions, such as prepaid variable forward contracts, equity swaps,

collars, exchange funds, or other transactions that hedge or offset any decrease in market

value of the Company’s equity securities, are prohibited by this Policy.

D.Purchases of the Company’s Securities on Margin; Pledging the Company’s

Securities to Secure Margin or Other Loans

Purchasing on margin means borrowing from a brokerage firm, bank or other entity

in order to purchase the Company’s securities (other than in connection with a cashless

exercise of stock options through a broker under the Company’s equity plans). Margin

purchases of the Company’s securities are prohibited by this Policy except as otherwise pre-

approved by the Board of Directors in each instance. Pledging the Company’s securities as

collateral to secure loans is prohibited, except as otherwise pre-approved by the Board of

Directors in each instance. This prohibition means, among other things, that, absent the prior

approval of the Board of Directors you cannot hold the Company’s securities in a “margin

account” (which would allow you to borrow against your holdings to buy securities).

E.Partnership Distributions

Nothing in this Policy is intended to limit the ability of a venture capital partnership

or other similar entity with which a director is affiliated to distribute Company securities to

its partners, members or other similar persons. It is the responsibility of each affected

director and the affiliated entity, in consultation with their own counsel (as appropriate), to

determine the timing of any distributions, based on all relevant facts and circumstances and

applicable securities laws.

VI.Rule 10b5-1 Trading Plans

The restrictions in this Policy, except for provisions set forth in the Additional Prohibited

Transactions section, do not apply to transactions under a trading plan (a “Trading Plan”) that

satisfies either:

●the conditions of Rule 10b5-1; or

●the elements of a non-Rule 10b5-1 trading arrangement as defined in Item 408(c)

of Regulation S-K; and

●the General Counsel has pre-approved.

The General Counsel may impose such other conditions on the implementation and

operation of a Trading Plan as the General Counsel deems necessary or advisable. 

An individual may only modify a Trading Plan outside of a blackout period and, in any

event, when the individual does not possess material nonpublic information. Modifications to

and early terminations of a Trading Plan are subject to pre-approval by the General Counsel.

Individuals may not adopt more than one Trading Plan at a time except under the limited

circumstances permitted by Rule 10b5-1 and subject to pre-approval by the General Counsel.

The Company also reserves the right from time to time to suspend, discontinue, or

otherwise prohibit transactions under a Trading Plan if the General Counsel or the Board of

Directors, in its discretion, determines that such suspension, discontinuation, or other prohibition

is in the best interests of the Company.

Compliance of a Trading Plan with the terms of Rule 10b5-1 and the execution of

transactions pursuant to the Trading Plan are the sole responsibility of the person initiating the

Trading Plan, and none of the Company, the General Counsel, or the Company’s other

employees assumes any liability for any delay in reviewing and/or refusing to approve a Trading

Plan submitted for approval, nor the legality or consequences relating to a person entering into,

informing the Company of, or trading under, a Trading Plan.

VII.Annual Policy Training and Compliance

All directors, officers, employees and others subject to this Policy may be asked to

participate in the annual training program to certify their compliance with the terms and

provisions of this Policy.

* * * * *

Effective Date: September 23, 2020

Updated: February 26, 2025